These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3264337)

  • 1. B cell activation in patients with active procainamide induced lupus.
    Forrester J; Golbus J; Brede D; Hudson J; Richardson B
    J Rheumatol; 1988 Sep; 15(9):1384-8. PubMed ID: 3264337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antibody to histone complex H2A-H2B with symptomatic procainamide-induced lupus.
    Totoritis MC; Tan EM; McNally EM; Rubin RL
    N Engl J Med; 1988 Jun; 318(22):1431-6. PubMed ID: 3259287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of CD70 and overstimulation of IgG synthesis by lupus T cells and T cells treated with DNA methylation inhibitors.
    Oelke K; Lu Q; Richardson D; Wu A; Deng C; Hanash S; Richardson B
    Arthritis Rheum; 2004 Jun; 50(6):1850-60. PubMed ID: 15188362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation in T cells from idiopathic lupus and drug-induced lupus patients.
    Zhou Y; Lu Q
    Autoimmun Rev; 2008 May; 7(5):376-83. PubMed ID: 18486925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG but not other classes of anti-[(H2A-H2B)-DNA] is an early sign of procainamide-induced lupus.
    Rubin RL; Burlingame RW; Arnott JE; Totoritis MC; McNally EM; Johnson AD
    J Immunol; 1995 Mar; 154(5):2483-93. PubMed ID: 7868914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolite of the lupus-inducing drug procainamide prevents anergy induction in T cell clones.
    Kretz-Rommel A; Rubin RL
    J Immunol; 1997 May; 158(9):4465-70. PubMed ID: 9127012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro production of antibodies to histones in patients receiving chronic procainamide therapy.
    Mongey AB; Hess E
    J Rheumatol; 2001 Sep; 28(9):1992-8. PubMed ID: 11550965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systemic lupus erythematosus-like syndrome induced by procainamide.
    Zeide MS; Wiesel S; Terry R; Stein D
    Clin Orthop Relat Res; 1978; (134):290-2. PubMed ID: 729256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red cell aplasia in procainamide induced systemic lupus erythematosus. Report and review of the literature.
    Agudelo CA; Wise CM; Lyles MF
    J Rheumatol; 1988 Sep; 15(9):1431-2. PubMed ID: 3143834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
    Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
    Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procainamide-induced systemic lupus erythematosus. Renal involvement with deposition of immune complexes.
    Whittle TS; Ainsworth SK
    Arch Pathol Lab Med; 1976 Sep; 100(9):469-74. PubMed ID: 782399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
    Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
    Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyradiculoneuropathy accompanying procainamide-induced lupus erythematosus: evidence for drug-induced enhanced sensitization to peripheral nerve myelin.
    Sahenk Z; Mendell JR; Rossio JL; Hurtubise P
    Ann Neurol; 1977 Apr; 1(4):378-84. PubMed ID: 617255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mononuclear phagocytes from patients with active systemic lupus erythematosus down-regulate the specific in vitro reactivity of autologous lymphocytes to double-stranded DNA.
    Weill BJ; Renoux ML
    Clin Exp Immunol; 1988 Apr; 72(1):43-9. PubMed ID: 3293851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLE: idiopathic or drug-induced?
    Condemi JJ
    Geriatrics; 1980 Mar; 35(3):81-8. PubMed ID: 6965485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating anticoagulant in the procainamide-induced lupus syndrome.
    Bell WR; Boss GR; Wolfson JS
    Arch Intern Med; 1977 Oct; 137(10):1471-3. PubMed ID: 921427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.